Home Health & Hospice Week

Industry Notes:

Enhabit Stock Slump Continues After Investment Firm Shareholder Demands Sale

At press time, the stock price of Enhabit Inc. was back in the basement after receiving a letter from shareholders urging a sale.

AREX Capital Management and its affiliates, which own nearly 5 percent of Enhabit’s shares, took the chain’s Board of Directors to task for what it describes as communi­cations errors. “This latest debacle has once again proven the already blindingly obvious point that Enhabit must not remain a standalone public company,” AREX blasts in the Oct. 5 letter. “We will act decisively to protect our rights if the Company has not announced a sale by early next year,” the investment firm threatens.

The company’s stock hit a 52-week low of $7.65 per share on Oct. 4, and after some minor fluctuation, at press time it was back down to $8.02. That compares to a 52-week high of $16.64.

Other Articles in this issue of

Home Health & Hospice Week

View All